-
公开(公告)号：US20130040917A1
公开(公告)日：2013-02-14
申请号：US13618019
申请日：2012-09-14
IPC分类号： A61K31/655 , A61P13/02 , C07D213/76
CPC分类号： C07D213/77 , C07D401/12
摘要： The present invention is directed to substituted phenazopyridines represented by Formula I. The present invention also relates to the discovery that compounds of Formula I have increased bioavailability as compared to unconjugated phenazopyridine.
摘要翻译： 本发明涉及由式I表示的取代的吩噻嗪类。本发明还涉及与未缀合的非那吡啶相比，式I化合物具有增加的生物利用度的发现。
-
公开(公告)号：US08288365B2
公开(公告)日：2012-10-16
申请号：US13014281
申请日：2011-01-26
IPC分类号： A61K31/655 , C07D213/76
CPC分类号： C07D213/77 , C07D401/12
摘要： The present invention is directed to substituted phenazopyridines represented by Formula I. The present invention also relates to the discovery that compounds of Formula I have increased bioavailability as compared to unconjugated phenazopyridine.
摘要翻译： 本发明涉及由式I表示的取代的吩噻嗪类。本发明还涉及与未缀合的非那吡啶相比，式I化合物具有增加的生物利用度的发现。
-
公开(公告)号：US20110319367A1
公开(公告)日：2011-12-29
申请号：US13014281
申请日：2011-01-26
IPC分类号： A61K31/655 , A61P25/04 , C07D213/76
CPC分类号： C07D213/77 , C07D401/12
摘要： The present invention is directed to substituted phenazopyridines represented by Formula I. The present invention also relates to the discovery that compounds of Formula I have increased bioavailability as compared to unconjugated phenazopyridine.
摘要翻译： 本发明涉及由式I表示的取代的吩噻嗪类。本发明还涉及与未缀合的非那吡啶相比，式I化合物具有增加的生物利用度的发现。
-
公开(公告)号：US07893042B2
公开(公告)日：2011-02-22
申请号：US12645099
申请日：2009-12-22
IPC分类号： A61K31/655 , C07D213/75 , A61P13/02
CPC分类号： C07D213/77 , C07D401/12
摘要： The present invention is directed to substituted phenazopyridines represented by Formula I. The present invention also relates to the discovery that compounds of Formula I have increased bioavailability as compared to unconjugated phenazopyridine.
摘要翻译： 本发明涉及由式I表示的取代的吩噻嗪类。本发明还涉及与未缀合的非那吡啶相比，式I化合物具有增加的生物利用度的发现。
-
公开(公告)号：US20100204185A1
公开(公告)日：2010-08-12
申请号：US12645099
申请日：2009-12-22
IPC分类号： A61K31/655 , C09B29/42 , A61P13/00
CPC分类号： C07D213/77 , C07D401/12
摘要： The present invention is directed to substituted phenazopyridines represented by Formula I. The present invention also relates to the discovery that compounds of Formula I have increased bioavailability as compared to unconjugated phenazopyridine.
摘要翻译： 本发明涉及由式I表示的取代的吩噻嗪类。本发明还涉及与未缀合的非那吡啶相比，式I化合物具有增加的生物利用度的发现。
-
-
-
-
搜索结果
5 条记录 (耗时 0.024 秒)
